Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hUC-MSCs for Systemic Lupus Erythematosus
NCT03219801Phase 1Unknown
- Sponsor
- Hebei Medical University
- Start
- Aug 2017
- Primary completion
- Dec 2018
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Human umbilical cord mesenchymal stem cells in systemic lupus erythematosus (SLE) (2 arms), sponsored by Hebei Medical University. Primary endpoint: Complement levels (C3 and C4) at 6 months. Status: unknown.
02
Drugs
Human umbilical cord mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03219801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219801.